// App-Quantinova.ai

: The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Researchers

Presenter

  • Theodoros P. Vassilakopoulos

Principal Investigators

  • Panagiotis T Diamantopoulos

  • Maria K. Angelopoulou

  • Gianpaolo Nadali

  • Gerasimos Tsourouflis

  • Maria Moschogiannis

  • Maria Dimopoulou

  • Marina Siakantaris

  • Xanthi Yiakoumis

  • Flora Kontopidou

  • Christina H. Kalpadakis

  • Gabriela Gainaru

  • John V. Asimakopoulos

  • Maria Dimou

  • Sotirios Sachanas

  • Marie-Christine Kyrtsonis

  • Panayiotis Tsaftaridis

  • Eleni Plata

  • Eleni Variami

  • Nora-Athina Viniou

  • Giovanni Pizzolo

  • Andreas H. Sarris

  • Kostas Konstantopoulos

  • Panayiotis Panayiotidis

  • Gerassimos Pangalis

Medical Centers

  • Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

  • First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

  • Department of Medicine, Section of Hematology, University of Verona, Verona, Italy

  • University Hospital of Crete, Heraklion, GRC

  • Laikon General Hospital, First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece

  • Hygeia Hospital, Athens, Greece

  • Hygeia Hospital, Maroussi, GRC

  • Azienda Ospedaliera Di Verona, Verona, ITA

  • Athens Medical Center-Psychikon Branch, Athens, GRC

  • Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Second Propedeutic Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Athens Medical Center, Athens, Greece

  • Second Department of Internal Medicine, National and Kapodistrian University of Athens, Hippokrateio General Hospital, Athens, Greece

  • Department of Hematology, University of Athens Medical School, Athens, Greece

  • First Propedeutic Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

  • Department of Haematology, Athens Medical Center, Psychikon Branch, Athens, Greece

  • Hematology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy

  • Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece

  • Section of Hematology, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy

  • First Department of Internal Medicine, Hematology Unit, Laikon General Hospital, Athens, Greece

  • Department of Hematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Locations

  • Greece

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved